1. Home
  2. CPIX vs IBIO Comparison

CPIX vs IBIO Comparison

Compare CPIX & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$6.79

Market Cap

98.3M

Sector

Health Care

ML Signal

HOLD

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$1.31

Market Cap

83.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPIX
IBIO
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.3M
83.5M
IPO Year
2007
2009

Fundamental Metrics

Financial Performance
Metric
CPIX
IBIO
Price
$6.79
$1.31
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.75
AVG Volume (30 Days)
70.4K
672.6K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
58.70
81.71
EPS
N/A
N/A
Revenue
$42,010,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.75
N/A
52 Week Low
$1.85
$0.77
52 Week High
$9.28
$3.82

Technical Indicators

Market Signals
Indicator
CPIX
IBIO
Relative Strength Index (RSI) 40.49 38.13
Support Level $5.55 $0.98
Resistance Level $7.36 $1.52
Average True Range (ATR) 0.64 0.07
MACD -0.23 -0.01
Stochastic Oscillator 12.67 29.27

Price Performance

Historical Comparison
CPIX
IBIO

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: